M4MM

Cresco Labs Reschedules Q1 2025 Earnings

LOS ANGELES- Cresco Labs Inc. has announced an updated schedule for its first quarter 2025 financial disclosures. The company will file its interim financial statements and Management’s Discussion and Analysis (MD&A) on Friday, May 30, ...

Cannabis in Psychedelic Therapy: Potential and Precautions

LOS ANGELES- The integration of cannabis into psychedelic-assisted psychotherapy is gaining attention as a potential treatment for various mental health conditions, including post-traumatic stress disorder (PTSD), depression, and anxiety. This approach involves administering cannabis in ...

Cybin Partners with Thermo Fisher for U.S. Manufacturing

LOS ANGELES- Cybin Inc. a neuropsychiatry company, has announced a collaboration with Thermo Fisher Scientific to support the Phase 3 clinical supply and potential commercial manufacturing of CYB003, its proprietary deuterated psilocin analog, for the ...

Rubicon Organics Appoints Glen Ibbott as Interim CFO

LOS ANGELES- Rubicon Organics Inc.  a Canadian producer of certified organic cannabis products, has appointed Glen Ibbott as Interim Chief Financial Officer, effective May 15, 2025. This leadership change follows the departure of Janis Risbin ...

Cresco Labs Reschedules Q1 2025 Earnings

LOS ANGELES- Cresco Labs Inc. has announced an updated schedule for its first quarter 2025 financial disclosures. The company will file its interim financial statements and Management’s Discussion and Analysis (MD&A) on Friday, May 30, ...

DEA Postpones Cannabis Rescheduling Hearing to 2025

LOS ANGELES- The Drug Enforcement Administration (DEA) has postponed its public hearing on the proposed rescheduling of cannabis under federal law. Initially scheduled for December 2, 2024, the hearing is now expected to occur in ...

What You Need to Know About Cash Flow Management

NEW YORK- Every CFO and entrepreneur in Cannabis and Psychedelics needs to know that efficient cash flow management is essential in the cannabis industry, where companies face specific financial challenges. WELCOME Back to this fresh ...

Cansortium Completes Merger with RIV Capital

LOS ANGELES- Cansortium Inc., operating under the Fluent brand, has finalized its merger with RIV Capital Inc., establishing a multi-state cannabis operator with a presence in Florida, New York, Texas, and Pennsylvania. The merger results ...

Psyence Biomed Completes $2 Million Private Placement

LOS ANGELES- Psyence Biomedical Ltd. , a biotechnology firm specializing in psilocybin-based psychedelic medicines, has finalized a private placement, securing approximately $2 million in gross proceeds. The financing involved the issuance of 1,000,000 common shares ...

Psyence Biomedical Regains Nasdaq Compliance

LOS ANGELES- Psyence Biomedical Ltd. (Nasdaq: PBM) has regained compliance with all Nasdaq continued listing requirements, as confirmed by the Nasdaq Hearings Panel. The company had previously requested a transfer from The Nasdaq Global Market ...

Subscribe To Our Newsletter